Biochemical Genetics

, Volume 47, Issue 9–10, pp 688–693

Apolipoprotein E Polymorphism in Hemodialyzed Patients and Healthy Controls

  • Jaroslav A. Hubacek
  • Silvie Bloudickova
  • Ruzena Kubinova
  • Hynek Pikhart
  • Ondrej Viklicky
  • Martin Bobak
Article

DOI: 10.1007/s10528-009-9266-y

Cite this article as:
Hubacek, J.A., Bloudickova, S., Kubinova, R. et al. Biochem Genet (2009) 47: 688. doi:10.1007/s10528-009-9266-y
  • 50 Downloads

Abstract

A possible association between end-stage renal disease (ESRD) and apolipoprotein E (APOE) polymorphism was found in some but not all studies. We have analyzed the APOE genotypes in 995 hemodialyzed patients (cases) and a sample of 6242 healthy individuals (controls) in the Czech Republic. There was a statistically significant difference in the frequency of APOE alleles between cases and controls, with more carriers of the APOE2 allele in ESRD patients (15.9%) than in controls (12.2%) (P = 0.005). The odds ratio of ESRD for the APOE2 allele, compared with APOE3E3 homozygotes, was 1.37 (95% confidence interval 1.13–1.67). The strength of the association increased with the time spent on hemodialysis: the odds ratio of all-cause ESRD in patients dialyzed for eight or more years was 1.27 (0.94–1.71), for 1–8 years 1.41 (1.09–1.81), and less than 1 year (nonsurvivors) 1.94 (0.88–4.18). This study suggests that the APOE2 allele is a possible genetic risk factor for all-cause ESRD in Caucasians.

Keywords

Apolipoprotein E End-stage renal disease Polymorphism 

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Jaroslav A. Hubacek
    • 1
    • 2
    • 3
  • Silvie Bloudickova
    • 1
  • Ruzena Kubinova
    • 4
  • Hynek Pikhart
    • 5
  • Ondrej Viklicky
    • 1
  • Martin Bobak
    • 5
  1. 1.Institute for Clinical and Experimental Medicine, CEM, Laboratory for Molecular GeneticsPrague 4Czech Republic
  2. 2.Third Internal Department, First Medical FacultyCharles UniversityPragueCzech Republic
  3. 3.Cardiovascular Research CentrePragueCzech Republic
  4. 4.National Institute of Public HealthPragueCzech Republic
  5. 5.Department of Epidemiology and Public HealthUniversity College LondonLondonUK

Personalised recommendations